Cadrenal Therapeutics Inc...

NASDAQ: CVKD · Real-Time Price · USD
12.70
-0.22 (-1.70%)
At close: Aug 15, 2025, 2:13 PM

Cadrenal Therapeutics Common Stock Revenue

Cadrenal Therapeutics Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Cadrenal Therapeutics Common Stock generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
4
Market Cap
26M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.